Yradionuclide generatorsystem [3] [4] [5] .Usingsuchelectrochemicaltechniques, thelowerconsumptionofreagentsandminimalgeneration ofradioactivewastearecompatiblewith"greenchemistry" principles [6] . [9] [10] [11] [12] .Regulationofangiogenesisis crucialformanydiseases.Antiangiogenictherapyfocusing onthetumourmicroenvironmentisatraditionalapproachfor treatingcancer [13] .Angiogenesisisacomplexprocessthat includesmultiplecelltypes,cytokines,adhesionmolecules, growthfactors,andsignaltransductionduringinflammation [14] . Radiotherapyforsurgeryandtumourtherapywasdeveloped morethanacenturyago.Higherdosesofradiotherapythat minimizeabsorbancebynormaltissueswillbethenext developmenttrend [15] .Radiationdamagetooculartissues includes conjunctivitis,eyelidlesions,keratitis,and keratoconjunctivitissicca [16] .Appropriateradiationtherapy haslongbeenattemptedforoculardiseases.Intraocular tumourslocatedintheiris,ciliarybody,andchoroidcould betreatedwithplaquebrachytherapy,exceptfortumours withorbitalextensionandnolightperceptionvision [17] . Endothelialdysfunctionhasbeenassociatedwithanumber ofpathophysiologicalprocesses.VEGF,whichissynthesized andreleasedbyendothelialcells,regulatesangiogenesis, vasculartoneandpermeability [18] [19] [20] .TheformationofCNVis dependentuponVEGF,aswellastheproliferationof vascularendothelium,remodellingofextracellularmatrix componentsandtheactivationofcytokines [21] .VEGFplaysa majorroleintheprocessofvesselbranchformation,leading toaberrantangiogenicresponses.Italsoplaysimportant rolesinmanydiseases [22] [23] [24] .Radiumapplicatorsandpurebeta emittershavebeenwidelyusedinthepasttotreatskin haemangiomainearlychildhood [25] .Highexpressionlevels ofVEGFhavebeenassociatedwithapoorprognosisin cancerpatients,indicatingthatVEGFcouldbelinkedtothe efficacyofradiotherapy [26] .VEGFisavaluablemolecular markerintreatmentoutcomesfollowingradiationtherapyfor rectaladenocarcinoma [27] .Radiationtherapycanalsoprovide adose-dependentbenefitinthetreatmentofneovascular age-relatedmaculardegeneration,whichcanreducethe frequencyofanti-VEGFinjectionstomaintainvisualacuity [28] . rejection [29] [30] . 
